Why Stage 4 Cancer Patient Decided to Try Psilocybin Study

This video is unavailable because we were unable to load a message from our sponsors.

If you are using ad-blocking software, please disable it and reload the page.

Johns Hopkins University launched a dedicated center for psychedelic studies, which is the first of its kind, and it’s changing lives. Tony joins Dr. Ian Smith to share about his experience being diagnosed with prostate cancer and participated in a psilocybin study. He was given 5-8 years to live after finding out his cancer metastasized, and that was 9 years ago.

How One Man’s Cancer Experience Changed after Psilocybin Treatment